Bruno Varet

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.

Philippe Rousselot, J. Reiffers, P. Rousselot, 2010, The Lancet. Oncology.

Caspase Activation Is Required for Terminal Erythroid Differentiation

Olivier Hermine, E. Solary, C. Garrido, 2001, The Journal of experimental medicine.

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

Sarah Zohar, R. Letestu, M. Cavazzana‐Calvo, 2007, Transfusion.

Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy1

L. Saveanu, L. Camoin, F. Guilhot, 2005, The Journal of Immunology.

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Patrick Mayeux, V. Ugo, N. Casadevall, 2002, The New England journal of medicine.

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells.

Jacques-Olivier Pers, Olivier Hermine, Antonio Cosma, 2008, Blood.

Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1

Olivier Hermine, E. Solary, C. Garrido, 2007, Nature.